My assumption is that the money will be used to hire regulatory consultants to begin the BLA process. Maybe they will also use some of the proceeds to start hiring the many people they will need to hire if they intend to bring DCVAX-L to market themselves, including hiring a Chief Regulatory Officer and/or Chief Marketing Officer.
We’re not in the inner circle. We do not know what constraints they were meeting but they are not well funded, so likely constraints of which we would not be aware.
Removing any constraints will accelerate the trial, and they likely have some key constraints in mind.